| Ident. | Authors (with country if any) | Title |
|---|
| 000473 (2020) |
Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis] | Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. |
| 000B02 (2019) |
Paul P. Geurink [Pays-Bas] ; Gerbrand J. Van Der Heden Van Noort [Pays-Bas] ; Monique P C. Mulder [Pays-Bas] ; Robert C M. Knaap [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Huib Ovaa [Pays-Bas] | Profiling DUBs and Ubl-specific proteases with activity-based probes. |
| 000C38 (2018) |
Robert N. Kirchdoerfer [États-Unis] ; Nianshuang Wang [États-Unis] ; Jesper Pallesen [États-Unis] ; Daniel Wrapp [États-Unis] ; Hannah L. Turner [États-Unis] ; Christopher A. Cottrell [États-Unis] ; Kizzmekia S. Corbett [États-Unis] ; Barney S. Graham [États-Unis] ; Jason S. Mclellan [États-Unis] ; Andrew B. Ward [États-Unis] | Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis |
| 000C66 (2018) |
Yuan Zheng [États-Unis] ; Jian Shang [États-Unis] ; Yang Yang [États-Unis] ; Chang Liu [États-Unis] ; Yushun Wan [États-Unis] ; Qibin Geng [États-Unis] ; Michelle Wang [États-Unis] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis] | Lysosomal Proteases Are a Determinant of Coronavirus Tropism |
| 000C90 (2018) |
Min-Han Lin [Taïwan] ; David C. Moses [Taïwan] ; Chih-Hua Hsieh [Taïwan] ; Shu-Chun Cheng [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan Chou [Taïwan] | Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. |
| 000F38 (2016) |
Fenghua Wang [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Kailin Yang [États-Unis] ; Haitao Yang [République populaire de Chine] | Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design |
| 000F39 (2016) |
Gang Ye [République populaire de Chine] ; Feng Deng [République populaire de Chine] ; Zhou Shen [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Ling Zhao [République populaire de Chine] ; Shaobo Xiao [République populaire de Chine] ; Zhen F. Fu [République populaire de Chine, États-Unis] ; Guiqing Peng [République populaire de Chine] | Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease |
| 000F54 (2016) |
Haofeng Wang ; Song Xue ; Haitao Yang ; Cheng Chen | Recent progress in the discovery of inhibitors targeting coronavirus proteases |
| 001007 (2016) |
Vathan Kumar [Taïwan] ; Kian-Pin Tan [Taïwan] ; Ying-Ming Wang [Taïwan] ; Sheng-Wei Lin [Taïwan] ; Po-Huang Liang [Taïwan] | Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. |
| 001253 (2015) |
Mikl S Békés [États-Unis] ; Wioletta Rut [Pologne] ; Paulina Kasperkiewicz [Pologne] ; Monique P C. Mulder [Pays-Bas] ; Huib Ovaa [Pays-Bas] ; Marcin Drag [Pologne] ; Christopher D. Lima [États-Unis] ; Tony T. Huang [États-Unis] | SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme. |
| 001370 (2015) |
Farah El Najjar [États-Unis] ; Levi Lampe [États-Unis] ; Michelle L. Baker [Australie] ; Lin-Fa Wang [Singapour] ; Rebecca Ellis Dutch [États-Unis] | Analysis of cathepsin and furin proteolytic enzymes involved in viral fusion protein activation in cells of the bat reservoir host. |
| 001530 (2014) |
Yahira M. Báez-Santos [États-Unis] ; Scott J. Barraza ; Michael W. Wilson ; Michael P. Agius ; Anna M. Mielech ; Nicole M. Davis ; Susan C. Baker ; Scott D. Larsen ; Andrew D. Mesecar | X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. |
| 001585 (2014) |
Xiaojuan Chen [République populaire de Chine] ; Xingxing Yang ; Yang Zheng ; Yudong Yang ; Yaling Xing ; Zhongbin Chen | SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. |
| 001612 (2014) |
Anna M. Mielech [États-Unis] ; Yafang Chen [États-Unis] ; Andrew D. Mesecar [États-Unis] ; Susan C. Baker [États-Unis] | Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities |
| 001643 (2014) |
Jean Kaoru Millet ; Gary R. Whittaker | Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis |
| 001650 (2014) |
Rolf Hilgenfeld | From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design |
| 001695 (2014) |
Yahira M. Báez-Santos [États-Unis] ; Anna M. Mielech [États-Unis] ; Xufang Deng [États-Unis] ; Susan Baker [États-Unis] ; Andrew D. Mesecar [États-Unis] | Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. |
| 001716 (2014) |
Xufang Deng [États-Unis] ; Sudhakar Agnihothram [États-Unis] ; Anna M. Mielech [États-Unis] ; Daniel B. Nichols [États-Unis] ; Michael W. Wilson [États-Unis] ; Sarah E. Stjohn [États-Unis] ; Scott D. Larsen [États-Unis] ; Andrew D. Mesecar [États-Unis] ; Deborah J. Lenschow [États-Unis] ; Ralph S. Baric [États-Unis] ; Susan C. Baker [États-Unis] | A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses. |
| 001904 (2013) |
Sivakoteswara Rao Mandadapu [États-Unis] ; Pathum M. Weerawarna ; Allan M. Prior ; Roxanne Adeline Z. Uy ; Sridhar Aravapalli ; Kevin R. Alliston ; Gerald H. Lushington ; Yunjeong Kim ; Duy H. Hua ; Kyeong-Ok Chang ; William C. Groutas | Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. |
| 001974 (2013) |
Christopher C. Stobart ; Nicole R. Sexton ; Havisha Munjal ; Xiaotao Lu ; Katrina L. Molland ; Sakshi Tomar ; Andrew D. Mesecar ; Mark R. Denison | Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity |
| 001981 (2013) |
Seiji Shibasaki ; Wataru Aoki ; Mitsuyoshi Ueda | Biochemical analysis and application of molecular display technology on Candida albicans for diagnosing and preventing candidiasis. |
| 001C75 (2012) |
Hyun Lee [États-Unis] ; Jaime Torres ; Lena Truong ; Rima Chaudhuri ; Anuradha Mittal ; Michael E. Johnson | Reducing agents affect inhibitory activities of compounds: results from multiple drug targets. |
| 002003 (2011) |
Shutoku Matsuyama [Japon] | [Protease-dependent cell entry mechanism of coronaviruses]. |
| 002063 (2011) |
Chi-Pang Chuck [République populaire de Chine] ; Hak-Fun Chow [République populaire de Chine] ; David Chi-Cheong Wan [République populaire de Chine] ; Kam-Bo Wong [République populaire de Chine] | Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses |
| 002127 (2011) |
Graham Simmons [États-Unis] ; Stephanie Bertram ; Ilona Glowacka ; Imke Steffen ; Chawaree Chaipan ; Juliet Agudelo ; Kai Lu ; Andrew J. Rennekamp ; Heike Hofmann ; Paul Bates ; Stefan Pöhlmann | Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion. |
| 002142 (2011) |
Rima Chaudhuri [États-Unis] ; Sishi Tang [États-Unis] ; Guijun Zhao [États-Unis] ; Hui Lu [États-Unis] ; David A. Case [États-Unis] ; Michael E. Johnson [États-Unis] | Comparison of SARS and NL63 Papain-Like Protease Binding Sites and Binding Site Dynamics: Inhibitor Design Implications |
| 002414 (2010) |
Keiji Kuba [Japon] ; Yumiko Imai [Japon] ; Takayo Ohto-Nakanishi [Japon] ; Josef M. Penninger [Autriche] | Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters |
| 002469 (2010) |
Holger Steuber [Allemagne] ; Rolf Hilgenfeld | Recent advances in targeting viral proteases for the discovery of novel antivirals. |
| 002972 (2009) |
Fumihiro Taguchi [Japon] ; Shutoku Matsuyama | [Cell entry mechanisms of coronaviruses]. |
| 002976 (2009) |
Jeffrey Anderson [États-Unis] ; Celia Schiffer ; Sook-Kyung Lee ; Ronald Swanstrom | Viral protease inhibitors. |
| 002A96 (2009) |
Chih-Jung Kuo ; Hun-Ge Liu ; Yueh-Kuei Lo ; Churl-Min Seong ; Kee-In Lee ; Young-Sik Jung ; Po-Huang Liang | Individual and common inhibitors of coronavirus and picornavirus main proteases |
| 002F70 (2008) |
Nan Zhong ; Shengnan Zhang ; Peng Zou ; Jiaxuan Chen ; Xue Kang ; Zhe Li ; Chao Liang ; Changwen Jin ; Bin Xia | Without Its N-Finger, the Main Protease of Severe Acute Respiratory Syndrome Coronavirus Can Form a Novel Dimer through Its C-Terminal Domain▿ |
| 003002 (2008) |
Xiaoyu Xue [République populaire de Chine] ; Hongwei Yu ; Haitao Yang ; Fei Xue ; Zhixin Wu ; Wei Shen ; Jun Li ; Zhe Zhou ; Yi Ding ; Qi Zhao ; Xuejun C. Zhang ; Ming Liao ; Mark Bartlam ; Zihe Rao | Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. |
| 003035 (2008) |
John Mark [Canada] ; Xuguang Li [Canada] ; Terry Cyr [Canada] ; Sylvie Fournier [Canada] ; Bozena Jaentschke [Canada] ; Mary Alice Hefford [Canada] | SARS coronavirus: unusual lability of the nucleocapsid protein. |
| 003052 (2008) |
Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Shutoku Matsuyama [Japon] ; Fumihiro Taguchi [Japon] | Protease-Mediated Entry via the Endosome of Human Coronavirus 229E▿ |
| 003103 (2008) |
Makoto Ujike [Japon] ; Hiroki Nishikawa ; Akira Otaka ; Naoki Yamamoto ; Norio Yamamoto ; Masao Matsuoka ; Eiichi Kodama ; Nobutaka Fujii ; Fumihiro Taguchi | Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway. |
| 003616 (2007) |
Santhana G. Devaraj [États-Unis] ; Nan Wang ; Zhongbin Chen ; Zihong Chen ; Monica Tseng ; Naina Barretto ; Rongtuan Lin ; Clarence J. Peters ; Chien-Te K. Tseng ; Susan C. Baker ; Kui Li | Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. |
| 003621 (2007) |
Kap-Sun Yeung [États-Unis] ; Nicholas A. Meanwell | Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus. |
| 003704 (2007) |
Kimberly Brucz [États-Unis] ; Zachary J. Miknis ; L Wayne Schultz ; Timothy C. Umland | Expression, purification and characterization of recombinant severe acute respiratory syndrome coronavirus non-structural protein 1. |
| 003D08 (2006) |
Kiira Ratia [États-Unis] ; Kumar Singh Saikatendu ; Bernard D. Santarsiero ; Naina Barretto ; Susan C. Baker ; Raymond C. Stevens ; Andrew D. Mesecar | Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. |
| 003D66 (2006) |
A J Turner [Royaume-Uni] ; N N Nalivaeva | Proteinase dysbalance in pathology: the neprilysin (NEP) and angiotensin-converting enzyme (ACE) families. |
| 003F07 (2006) |
Shutoku Matsuyama [Japon] ; Makoto Ujike ; Koji Ishii ; Shuetsu Fukushi ; Shigeru Morikawa ; Masato Tashiro ; Fumihiro Taguchi | Enhancement of SARS-CoV infection by proteases. |
| 004576 (2005) |
Daniel W. Lambert [Royaume-Uni] ; Mike Yarski ; Fiona J. Warner ; Paul Thornhill ; Edward T. Parkin ; A Ian Smith ; Nigel M. Hooper ; Anthony J. Turner | Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). |
| 004707 (2005) |
Shutoku Matsuyama [Japon] ; Makoto Ujike ; Shigeru Morikawa ; Masato Tashiro ; Fumihiro Taguchi | Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. |
| 004751 (2005) |
Qishi Du [République populaire de Chine] ; Shuqing Wang ; Dongqing Wei ; Suzanne Sirois ; Kuo-Chen Chou | Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase. |
| 004823 (2005) |
Xue Wu Zhang [Hong Kong] ; Yee Leng Yap ; Ralf M. Altmeyer | Generation of predictive pharmacophore model for SARS-coronavirus main proteinase. |
| 004835 (2005) |
Xun Zuo [États-Unis] ; Michael R. Mattern ; Robin Tan ; Shuisen Li ; John Hall ; David E. Sterner ; Joshua Shoo ; Hiep Tran ; Peter Lim ; Stefan G. Sarafianos ; Lubna Kazi ; Sonia Navas-Martin ; Susan R. Weiss ; Tauseef R. Butt | Expression and purification of SARS coronavirus proteins using SUMO-fusions. |
| 004910 (2005) |
Haroon Ashraf | Cathepsin enzyme provides clue to SARS infection. |
| 004D37 (2005) |
Naina Barretto [États-Unis] ; Dalia Jukneliene [États-Unis] ; Kiira Ratia [États-Unis] ; ZHONGBIN CHEN [États-Unis, République populaire de Chine] ; Andrew D. Mesecar [États-Unis] ; Susan C. Baker [États-Unis] | The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity |
| 004D38 (2005) |
Holger A. Lindner [Canada] ; Nasser Fotouhi-Ardakani [Canada] ; Viktoria Lytvyn [Canada] ; Paule Lachance [Canada] ; Traian Sulea [Canada] ; Robert Menard [Canada] | The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme |
| 005482 (2004) |
Anthony J. Turner [Royaume-Uni] ; Julian A. Hiscox ; Nigel M. Hooper | ACE2: from vasopeptidase to SARS virus receptor. |
